Modified Duke Criteria

About The Modified Duke Criteria

The Modified Duke Criteria is a widely used clinical tool to diagnose Infective Endocarditis (IE). Because IE can present with a wide variety of symptoms, these criteria help clinicians weigh microbiological, echocardiographic, and clinical evidence to reach a diagnosis.

This calculator applies the Modified Duke Criteria (Li et al., 2000), which remain in wide clinical use. Note that the 2023 Duke-ISCVID Criteria — endorsed by the 2023 ESC endocarditis guideline — are now the most current standard. They retain the same Definite, Possible, and Rejected thresholds but add new major criteria (cardiac CT and ¹⁸F-FDG PET/CT imaging, intraoperative findings) and additional typical pathogens, and expand the minor criteria. Always interpret results alongside current guidelines and clinical judgment.

Clinical Presentation

Infective endocarditis usually presents as an acute or subacute infection. Key signs and symptoms include:

• Constitutional Symptoms: Fever (most common, >90%), chills, fatigue, malaise, night sweats, and weight loss.
• Cardiac Signs: New or changing heart murmur (85% of cases), signs of heart failure (dyspnea, edema).
• Peripheral Stigmata:
  • Petechiae: Common on palate, conjunctiva, or extremities.
  • Splinter Hemorrhages: Non-tender, dark linear streaks under fingernails.
  • Janeway Lesions: Non-tender, erythematous macules on palms/soles (Embolic).
  • Osler’s Nodes: Tender, subcutaneous nodules on finger/toe pads (Immunologic).
  • Roth Spots: Retinal hemorrhages with pale centers.
• Embolic Events: Stroke, pulmonary embolism, splenic infarction, or renal infarction.

When to Suspect IE?

Consider Infective Endocarditis in any patient with:

• Fever of unknown origin (FUO).
• New heart murmur or worsening of existing murmur.
• Positive blood cultures (especially Staph, Strep, or Enterococcus).
• Embolic events of unknown origin.
• History of prosthetic valve, prior IE, or IV drug use.

Treatment Guidelines

👉 View Complete Infective Endocarditis Treatment Guideline

Treatment requires prolonged bactericidal antibiotics (usually 4-6 weeks). Empiric therapy is started after obtaining blood cultures:

1. Native Valve Endocarditis

• Target: Streptococci, Staphylococci, Enterococci.
• Regimen: Ampicillin/Sulbactam (12g/day) OR Ceftriaxone (2g/day) PLUS Vancomycin.

2. Prosthetic Valve Endocarditis

• Target: MRSA, CNS, Gram-negative bacilli.
• Regimen: Vancomycin + Gentamicin + Rifampin (Rifampin is critical for penetrating biofilm).

Complications

Serious complications occur in up to 50% of patients and may require surgical intervention:

• Heart Failure: Due to severe valve regurgitation.
• Uncontrolled Infection: Abscess formation, enlarging vegetation, or persistent fever.
• Systemic Embolization: Stroke, limb ischemia, or splenic/renal infarcts.

Frequently Asked Questions (FAQ)

1. What is “Culture-Negative” Endocarditis?

In about 5-10% of cases, blood cultures remain negative despite clinical evidence of IE. This is most commonly caused by prior antibiotic administration before blood cultures were drawn. Other causes include infection with fastidious organisms (e.g., HACEK group, Coxiella burnetii, Bartonella species) that require specific serological testing or PCR.

2. Who needs antibiotic prophylaxis?

Current guidelines restrict antibiotic prophylaxis to the highest-risk patients undergoing dental procedures that involve manipulation of gingival tissue. High-risk groups include: patients with prosthetic heart valves, a history of previous infective endocarditis, and certain types of uncorrected congenital heart disease. Routine prophylaxis for GI or GU procedures is no longer recommended.

3. When is TEE (Transesophageal Echo) indicated?

A Transthoracic Echocardiogram (TTE) is the initial test of choice. However, TEE is recommended if TTE is negative or non-diagnostic but clinical suspicion remains high. TEE is also the primary imaging modality for patients with prosthetic valves, intracardiac devices (like pacemakers), or when complications such as abscesses are suspected, as it offers superior sensitivity.

4. What is the difference between Janeway lesions and Osler’s nodes?

These are classic peripheral signs of IE but have different pathophysiology. Janeway lesions are non-tender, flat, erythematous spots on the palms or soles caused by septic emboli (vascular phenomenon). Osler’s nodes are painful, raised, red nodules on the pads of fingers or toes caused by immune complex deposition (immunologic phenomenon).

5. Can I use the Duke Criteria for right-sided endocarditis?

Yes, the criteria apply to both left and right-sided IE. Right-sided endocarditis, often associated with IV drug use, frequently involves the tricuspid valve. In these cases, “septic pulmonary infarcts” (a minor criterion under Vascular Phenomena) are a key finding, often presenting as cavitary lung nodules on imaging.

6. How do the 2023 Duke-ISCVID criteria differ from the Modified Duke criteria?

The 2023 Duke-ISCVID criteria update the Modified Duke criteria (Li 2000) and are endorsed by the 2023 ESC guideline. They keep the same Definite, Possible, and Rejected thresholds but add new major criteria — including cardiac CT and ¹⁸F-FDG PET/CT imaging and intraoperative findings — along with additional typical pathogens (e.g., Staphylococcus lugdunensis, Enterococcus faecalis) and expanded minor criteria. This calculator computes the Modified Duke (2000) classification; apply current guidelines when interpreting borderline cases.

Related Calculators

• Infective Endocarditis Treatment Guideline
• qSOFA Score Calculator
• SOFA Score Calculator